182 related articles for article (PubMed ID: 11298075)
1. Frequency of cytochrome P450 2C9 mutant alleles in a Korean population.
Yoon YR; Shon JH; Kim MK; Lim YC; Lee HR; Park JY; Cha IJ; Shin JG
Br J Clin Pharmacol; 2001 Mar; 51(3):277-80. PubMed ID: 11298075
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P4502C9 (CYP2C9) allele frequencies in Canadian Native Indian and Inuit populations.
Gaedigk A; Casley WL; Tyndale RF; Sellers EM; Jurima-Romet M; Leeder JS
Can J Physiol Pharmacol; 2001 Oct; 79(10):841-7. PubMed ID: 11697742
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population.
Scordo MG; Aklillu E; Yasar U; Dahl ML; Spina E; Ingelman-Sundberg M
Br J Clin Pharmacol; 2001 Oct; 52(4):447-50. PubMed ID: 11678789
[TBL] [Abstract][Full Text] [Related]
4. High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population.
García-Martín E; Martínez C; Ladero JM; Gamito FJ; Agúndez JA
Eur J Clin Pharmacol; 2001 Apr; 57(1):47-9. PubMed ID: 11372590
[TBL] [Abstract][Full Text] [Related]
5. Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population.
Yasar U; Eliasson E; Dahl ML; Johansson I; Ingelman-Sundberg M; Sjöqvist F
Biochem Biophys Res Commun; 1999 Jan; 254(3):628-31. PubMed ID: 9920790
[TBL] [Abstract][Full Text] [Related]
6. Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin.
Aynacioglu AS; Brockmöller J; Bauer S; Sachse C; Güzelbey P; Ongen Z; Nacak M; Roots I
Br J Clin Pharmacol; 1999 Sep; 48(3):409-15. PubMed ID: 10510154
[TBL] [Abstract][Full Text] [Related]
7. The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism.
Sullivan-Klose TH; Ghanayem BI; Bell DA; Zhang ZY; Kaminsky LS; Shenfield GM; Miners JO; Birkett DJ; Goldstein JA
Pharmacogenetics; 1996 Aug; 6(4):341-9. PubMed ID: 8873220
[TBL] [Abstract][Full Text] [Related]
8. Roles of two allelic variants (Arg144Cys and Ile359Leu) of cytochrome P4502C9 in the oxidation of tolbutamide and warfarin by human liver microsomes.
Yamazaki H; Inoue K; Shimada T
Xenobiotica; 1998 Feb; 28(2):103-15. PubMed ID: 9522436
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of warfarin elimination and its clinical implications.
Takahashi H; Echizen H
Clin Pharmacokinet; 2001; 40(8):587-603. PubMed ID: 11523725
[TBL] [Abstract][Full Text] [Related]
10. Relationship between CYP2C9 and 2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4'-hydroxylation activities in livers of Japanese and Caucasian populations.
Inoue K; Yamazaki H; Imiya K; Akasaka S; Guengerich FP; Shimada T
Pharmacogenetics; 1997 Apr; 7(2):103-13. PubMed ID: 9170147
[TBL] [Abstract][Full Text] [Related]
11. Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin.
Kidd RS; Curry TB; Gallagher S; Edeki T; Blaisdell J; Goldstein JA
Pharmacogenetics; 2001 Dec; 11(9):803-8. PubMed ID: 11740344
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.
Lee CR; Goldstein JA; Pieper JA
Pharmacogenetics; 2002 Apr; 12(3):251-63. PubMed ID: 11927841
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer risk in relation to the CYP2C9*1/CYP2C9*2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California.
London SJ; Daly AK; Leathart JB; Navidi WC; Idle JR
Pharmacogenetics; 1996 Dec; 6(6):527-33. PubMed ID: 9014202
[TBL] [Abstract][Full Text] [Related]
14. Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population.
Hamdy SI; Hiratsuka M; Narahara K; El-Enany M; Moursi N; Ahmed MS; Mizugaki M
Br J Clin Pharmacol; 2002 Jun; 53(6):596-603. PubMed ID: 12047484
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population.
Kimura M; Ieiri I; Mamiya K; Urae A; Higuchi S
Ther Drug Monit; 1998 Jun; 20(3):243-7. PubMed ID: 9631918
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism in exon 4 of cytochrome P450 CYP2C9 may be associated with warfarin sensitivity in Chinese patients.
Leung AY; Chow HC; Kwong YL; Lie AK; Fung AT; Chow WH; Yip AS; Liang R
Blood; 2001 Oct; 98(8):2584-7. PubMed ID: 11588061
[TBL] [Abstract][Full Text] [Related]
17. Allele and genotype frequencies of CYP2C9 within an Iranian population (Mazandaran).
Hashemi-Soteh SM; Shahabi-Majd N; Gholizadeh AR; Shiran MR
Genet Test Mol Biomarkers; 2012 Jul; 16(7):817-21. PubMed ID: 22288731
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus.
Imai J; Ieiri I; Mamiya K; Miyahara S; Furuumi H; Nanba E; Yamane M; Fukumaki Y; Ninomiya H; Tashiro N; Otsubo K; Higuchi S
Pharmacogenetics; 2000 Feb; 10(1):85-9. PubMed ID: 10739176
[No Abstract] [Full Text] [Related]
19. Influence of cytochrome P450 CYP2C9 genotypes in lung cancer risk.
García-Martín E; Martínez C; Ladero JM; Gamito FJ; Rodriguez-Lescure A; Agúndez JA
Cancer Lett; 2002 Jun; 180(1):41-6. PubMed ID: 11911968
[TBL] [Abstract][Full Text] [Related]
20. Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced hepatitis.
Aithal GP; Day CP; Leathart JB; Daly AK
Pharmacogenetics; 2000 Aug; 10(6):511-8. PubMed ID: 10975605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]